130 related articles for article (PubMed ID: 16202817)
1. Immunohistochemical study in dural arteriovenous fistulas and possible role of local hypoxia for the de novo formation of dural arteriovenous fistulas.
Tirakotai W; Bertalanffy H; Liu-Guan B; Farhoud A; Sure U
Clin Neurol Neurosurg; 2005 Oct; 107(6):455-60. PubMed ID: 16202817
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical study in dural arteriovenous fistula and possible role of ephrin-B2 for development of dural arteriovenous fistula.
Tirakotai W; Bian LG; Bertalanffy H; Siegfried B; Sure U
Chin Med J (Engl); 2004 Dec; 117(12):1815-20. PubMed ID: 15603710
[TBL] [Abstract][Full Text] [Related]
3. Biological activity of adult cavernous malformations: a study of 56 patients.
Sure U; Freman S; Bozinov O; Benes L; Siegel AM; Bertalanffy H
J Neurosurg; 2005 Feb; 102(2):342-7. PubMed ID: 15739564
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia-inducible factor and vascular endothelial growth factor are expressed more frequently in embolized than in nonembolized cerebral arteriovenous malformations.
Sure U; Battenberg E; Dempfle A; Tirakotai W; Bien S; Bertalanffy H
Neurosurgery; 2004 Sep; 55(3):663-9; discussion 669-70. PubMed ID: 15335434
[TBL] [Abstract][Full Text] [Related]
5. Expression of angiogenic growth factors in dural arteriovenous fistula.
Uranishi R; Nakase H; Sakaki T
J Neurosurg; 1999 Nov; 91(5):781-6. PubMed ID: 10541235
[TBL] [Abstract][Full Text] [Related]
6. Endothelial proliferation, neoangiogenesis, and potential de novo generation of cerebrovascular malformations.
Sure U; Butz N; Schlegel J; Siegel AM; Wakat JP; Mennel HD; Bien S; Bertalanffy H
J Neurosurg; 2001 Jun; 94(6):972-7. PubMed ID: 11409527
[TBL] [Abstract][Full Text] [Related]
7. Biological activity of paediatric cerebral cavernomas: an immunohistochemical study of 28 patients.
Tirakotai W; Fremann S; Soerensen N; Roggendorf W; Siegel AM; Mennel HD; Zhu Y; Bertalanffy H; Sure U
Childs Nerv Syst; 2006 Jul; 22(7):685-91. PubMed ID: 16489474
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia inducible factor-1 alpha and vascular endothelial growth factor in biopsies of small cell lung carcinoma.
Ioannou M; Papamichali R; Kouvaras E; Mylonis I; Vageli D; Kerenidou T; Barbanis S; Daponte A; Simos G; Gourgoulianis K; Koukoulis GK
Lung; 2009; 187(5):321-9. PubMed ID: 19707816
[TBL] [Abstract][Full Text] [Related]
9. Axial shortening during distraction osteogenesis leads to enhanced bone formation in a rabbit model through the HIF-1alpha/vascular endothelial growth factor system.
Mori S; Akagi M; Kikuyama A; Yasuda Y; Hamanishi C
J Orthop Res; 2006 Apr; 24(4):653-63. PubMed ID: 16514629
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia inducible factor-1 alpha plays a pivotal role in hepatic metastasis of pancreatic cancer: an immunohistochemical study.
Matsuo Y; Ding Q; Desaki R; Maemura K; Mataki Y; Shinchi H; Natsugoe S; Takao S
J Hepatobiliary Pancreat Sci; 2014 Feb; 21(2):105-12. PubMed ID: 23798470
[TBL] [Abstract][Full Text] [Related]
11. Endothelial PAS domain protein 1 gene promotes angiogenesis through the transactivation of both vascular endothelial growth factor and its receptor, Flt-1.
Takeda N; Maemura K; Imai Y; Harada T; Kawanami D; Nojiri T; Manabe I; Nagai R
Circ Res; 2004 Jul; 95(2):146-53. PubMed ID: 15192019
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia inducible factor-1alpha and expression of vascular endothelial growth factor and its receptors in cerebral arteriovenous malformations.
Ng I; Tan WL; Ng PY; Lim J
J Clin Neurosci; 2005 Sep; 12(7):794-9. PubMed ID: 16165361
[TBL] [Abstract][Full Text] [Related]
13. Expression of structural proteins and angiogenic factors in cerebrovascular anomalies.
Kiliç T; Pamir MN; Küllü S; Eren F; Ozek MM; Black PM
Neurosurgery; 2000 May; 46(5):1179-91; discussion 1191-2. PubMed ID: 10807251
[TBL] [Abstract][Full Text] [Related]
14. Vascular endothelial growth factor, its receptor Flk-1, and hypoxia inducible factor-1alpha are involved in malignant transformation in dysplastic nodules of the liver.
Nakamura K; Zen Y; Sato Y; Kozaka K; Matsui O; Harada K; Nakanuma Y
Hum Pathol; 2007 Oct; 38(10):1532-46. PubMed ID: 17640715
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical analysis of growth mechanisms in juvenile nasopharyngeal angiofibroma.
Schuon R; Brieger J; Heinrich UR; Roth Y; Szyfter W; Mann WJ
Eur Arch Otorhinolaryngol; 2007 Apr; 264(4):389-94. PubMed ID: 17177025
[TBL] [Abstract][Full Text] [Related]
16. Treatment-induced neoangiogenesis in cerebral arteriovenous malformations.
Sure U; Butz N; Siegel AM; Mennel HD; Bien S; Bertalanffy H
Clin Neurol Neurosurg; 2001 Apr; 103(1):29-32. PubMed ID: 11311473
[TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor, FLT-1, and FLK-1 analysis in a pancreatic cancer tissue microarray.
Chung GG; Yoon HH; Zerkowski MP; Ghosh S; Thomas L; Harigopal M; Charette LA; Salem RR; Camp RL; Rimm DL; Burtness BA
Cancer; 2006 Apr; 106(8):1677-84. PubMed ID: 16532435
[TBL] [Abstract][Full Text] [Related]
18. Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer.
Takahashi Y; Kitadai Y; Bucana CD; Cleary KR; Ellis LM
Cancer Res; 1995 Sep; 55(18):3964-8. PubMed ID: 7664263
[TBL] [Abstract][Full Text] [Related]
19. Molecular angiogenic signaling in angiofibromas after embolization: implications for therapy.
Ngan BY; Forte V; Campisi P
Arch Otolaryngol Head Neck Surg; 2008 Nov; 134(11):1170-6. PubMed ID: 19015446
[TBL] [Abstract][Full Text] [Related]
20. HIF-1alpha-mediated up-regulation of vascular endothelial growth factor, independent of basic fibroblast growth factor, is important in the switch to the angiogenic phenotype during early tumorigenesis.
Fang J; Yan L; Shing Y; Moses MA
Cancer Res; 2001 Aug; 61(15):5731-5. PubMed ID: 11479208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
